Electromyography Devices Market Summary
The global electromyography devices market size was estimated at USD 1,233.7 million in 2025 and is expected to reach USD 2,095.3 million by 2035, growing at a CAGR of 5.4% from 2025 to 2035. Major growth drivers include rising neuromuscular disorders, demand for accurate diagnostics, portable devices, AI-enabled technologies, and expanding use in healthcare and rehabilitation settings.
According to the World Health Organization (WHO), neurological disorders affect approximately 1 billion people globally, significantly increasing the need for diagnostic tools like electromyography devices for early detection and monitoring.
Key Market Trends & Highlights
The Electromyography Devices Market is experiencing robust growth driven by technological advancements and increasing demand for patient-centric solutions.
- Technological advancements are enhancing the accuracy and efficiency of electromyography devices, thereby improving diagnostic capabilities.
- There is a notable shift towards portable electromyography devices, catering to the growing preference for at-home and on-the-go healthcare solutions.
- The focus on patient-centric solutions is reshaping product development, particularly in the rehabilitation segment, which is witnessing rapid growth.
- Rising prevalence of neuromuscular disorders and increased demand for rehabilitation services are key drivers propelling market expansion in North America and Asia-Pacific.
Market Size & Forecast
| 2024 Market Size | 1170.0 (USD Million) |
| 2035 Market Size | 2095.3 (USD Million) |
| CAGR (2025 - 2035) | 5.44% |
Major Players
Natus Medical Incorporated (US), Medtronic plc (IE), NeuroMetrix Inc. (US), Dantec Dynamics A/S (DK), Cadwell Industries, Inc. (US), Compumedics Limited (AU), MediGus (GB), Zebris Medical GmbH (DE), MyoPowers (US)